[Abstract] Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestinal tract and is primarily comprised of Crohn's disease (CD) and ulcerative colitis (UC). Several murine models that include both chemical induced and genetic models have been developed that mimic some aspects of either CD or UC. These models have been instrumental in our understanding of IBD. Of the chemical induced colitis models, dextran sodium sulfate (DSS) induced colitis model is a relatively simple and very widely used model of experimental colitis.
5. Dextran sodium sulfate (DSS) (TdB Consultancy, catalog number: DB001, molecular weight:
35-55 kDa)
Note: Stored in a dry place at room temperature. 3. For an injury repair model, 2% DSS (i.e., 2 g in 100 ml) in the drinking water is administered for the first 7 days followed by regular drinking water for another 7 days. However, the number of days on DSS followed by regular water can be changed based on the question in study. For example, if the question in study does not involve the recovery or the repair phase, then the DSS administration can be terminated either on day 7 or can be continued if prolonged inflammatory phase is desired. In order to determine the survival rate, 3% DSS in the drinking water can be administered until all the mice in either the control or the experimental group reach a humane endpoint. Ideally, the humane endpoint is when the mice have arrived the stipulated body weight loss approved by the ethical committee. In addition, severe and bloody diarrhea accompanied by hunched position, ruffled fur and reduced mobility are considered to be humane endpoint and the mice should be sacrificed by approved methods.
4. Mice treated with DSS will lose a significant amount of body weight and therefore, should be weighed daily to monitor the health and to ensure that mice are sacrificed at a humane endpoint based on the approved ethical standards. Additionally, the mice should be monitored daily for the stool consistency (0 = well formed stool pellet, 2 = semi-formed stool, 4 = liquid stool that adhere to anal region) and blood in the stool (0 = no blood, 2 = blood trace in the stool clearly visible, 4 = gross rectal bleeding). The individual recording this information should be blinded to the study. Loss of body weight, diarrhea and fecal bleeding score can be plotted to determine the effect of DSS induced colitis between mice of different genotypes and/or treatment groups.
As a general guideline, mice start to lose body weight around day 6 of DSS treatment and continue to lose weight approximately till day 10 (3 days after DSS removal) that is approximately 15-20% less than the initial body weight. During this time, the mice display behavioral changes such as reduced appetite, hunched back posture, ruffled fur etc. Following day 10, mice usually start to gain body weight and reaches the initial body weight by around day 14. However, this can vary depending on microbiota composition, animal facility and therefore should be carefully interpreted.
5. Following the cycles of DSS (7 days) and regular water (7 days), on day 14, mice can be euthanized according to the appropriate method approved by the ethical committee (IACUC).
Colon length should be measured using a ruler or Vernier calipers as DSS administration leads to swelling and shortening of colon. Pieces of colon (~0.5 cm) can be snap frozen in liquid nitrogen to be further processed for RNA extraction and gene expression analysis. For histology, the rest of the tissues can be Swiss rolled and stored in 10% buffered formalin using Tissue www.bio-protocol.org/e2515 (Table 1) using a Tissue-Tek VIP processing machine followed by paraffin embedding. Committee (IACUC) of the respective institutions. The animals involved in this study must be treated humanely, and in all situations in which the mice are used, pain and discomfort should be minimized.
It is important not to mix mice from different sources as they may have different microbiome
compositions that may alter the outcome of DSS induced colitis. Additionally, when using mice that are genetically modified, littermate controls are advised unless the role of maternal contribution (e.g., in-utero or vertical transfer) from a specific genotype is being studied.
3. Molecular weight of DSS is highly critical (molecular weight: 35-55 kDa).
